Shenzhen Cost Of Revenue from 2010 to 2024
| 300942 Stock | 8.48 0.50 5.57% |
Cost Of Revenue | First Reported 2010-12-31 | Previous Quarter 127.2 M | Current Value 131.8 M | Quarterly Volatility 74.8 M |
Check Shenzhen Bioeasy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shenzhen Bioeasy's main balance sheet or income statement drivers, such as Tax Provision of 14 M, Interest Expense of 11.2 M or Selling General Administrative of 76.7 M, as well as many indicators such as . Shenzhen financial statements analysis is a perfect complement when working with Shenzhen Bioeasy Valuation or Volatility modules.
Shenzhen | Cost Of Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shenzhen Stock
Shenzhen Bioeasy financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Bioeasy security.